Vitamin D and type 2 diabetes

作者: Paul Lips , Marelise Eekhoff , Natasja van Schoor , Mirjam Oosterwerff , Renate de Jongh

DOI: 10.1016/J.JSBMB.2016.11.021

关键词: EndocrinologyVitamin D and neurologyType 2 diabetesImpaired fasting glucoseInsulin resistancevitamin D deficiencyMedicineInsulinPrediabetesInternal medicineImpaired glucose tolerance

摘要: Vitamin D deficiency is associated with a decreased insulin release, resistance and type 2 diabetes in experimental epidemiological studies. Animal studies show that 1α,25-dihydroxyvitamin D3 (1,25(OH)2D3) stimulates the pancreatic β-cell to secrete insulin. The relationship between vitamin could develop through inflammation, as increased inflammatory markers. In addition, genetic polymorphisms of -related genes may predispose impaired glycemic control diabetes. Epidemiologic showed an association low serum 25-hydroxyvitamin (25(OH)D3) concentration risk for metabolic syndrome This be partly explained by fat mass. A possible causal should proven randomized clinical trials showing either can prevented or release sensitivity improved supplements. results on effect versus placebo, sometimes combined calcium, patients glucose tolerance ("prediabetes") are inconsistent. Some slight decrease fasting plasma improvement resistance, but often only posthoc analyses. These effects mainly visible at baseline. Meta-analyses general did not significant supplementation control. Currently, several large scale doses 1600-4000IU/d ongoing incidence mellitus outcome. needs cured, until these published, high-dose cannot recommended prevention amelioration

参考文章(45)
Tomi-Pekka Tuomainen, Jyrki K. Virtanen, Sari Voutilainen, Tarja Nurmi, Jaakko Mursu, Vanessa D. F. de Mello, Ursula Schwab, Martti Hakumäki, Kari Pulkki, Matti Uusitupa, Glucose Metabolism Effects of Vitamin D in Prediabetes: The VitDmet Randomized Placebo-Controlled Supplementation Study. Experimental Diabetes Research. ,vol. 2015, pp. 672653- 672653 ,(2015) , 10.1155/2015/672653
G. Grimnes, N. Emaus, R. M. Joakimsen, Y. Figenschau, T. Jenssen, I. Njølstad, H. Schirmer, R. Jorde, Baseline serum 25-hydroxyvitamin D concentrations in the Tromsø Study 1994-95 and risk of developing type 2 diabetes mellitus during 11 years of follow-up. Diabetic Medicine. ,vol. 27, pp. 1107- 1115 ,(2010) , 10.1111/J.1464-5491.2010.03092.X
Mirjam M. Oosterwerff, Elisabeth M. W. Eekhoff, Martijn W. Heymans, Paul Lips, Natasja M. van Schoor, Serum 25-hydroxyvitamin D levels and the metabolic syndrome in older persons: a population-based study. Clinical Endocrinology. ,vol. 75, pp. 608- 613 ,(2011) , 10.1111/J.1365-2265.2011.04110.X
Ohk-Hyun Ryu, Sungwha Lee, Jaemyung Yu, Moon-Gi Choi, Hyung Joon Yoo, Franco Mantero, A prospective randomized controlled trial of the effects of vitamin D supplementation on long-term glycemic control in type 2 diabetes mellitus of Korea Endocrine Journal. ,vol. 61, pp. 167- 176 ,(2014) , 10.1507/ENDOCRJ.EJ13-0356
Shirley Elkassaby, Leonard C. Harrison, Namita Mazzitelli, John M. Wentworth, Peter G. Colman, Timothy Spelman, Spiros Fourlanos, A randomised controlled trial of high dose vitamin D in recent-onset type 2 diabetes Diabetes Research and Clinical Practice. ,vol. 106, pp. 576- 582 ,(2014) , 10.1016/J.DIABRES.2014.08.030
Marjan Tabesh, Leila Azadbakht, Elham Faghihimani, Maryam Tabesh, Ahmad Esmaillzadeh, Effects of calcium–vitamin D co-supplementation on metabolic profiles in vitamin D insufficient people with type 2 diabetes: a randomised controlled clinical trial Diabetologia. ,vol. 57, pp. 2038- 2047 ,(2014) , 10.1007/S00125-014-3313-X